Ignite Creation Date:
2025-12-24 @ 6:57 PM
Ignite Modification Date:
2026-07-20 @ 3:47 PM
Study NCT ID:
NCT00946257
Status:
COMPLETED
Last Update Posted:
2017-06-01
First Post:
2009-07-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Subcutaneous Administration of Otelixizumab to T1DM Patients
Sponsor:
Organization: